Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Confirmation of the Link Between Endocrine Disruptors Exposure and Breast Cancer and Identification of Biological Response Biomarkers

NCT07411651 is registered in ClinicalTrials.gov with Poitiers University Hospital as lead sponsor.

NCT NCT07411651
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07411651 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Confirmation of the Link Between Endocrine Disruptors Exposure and Breast Cancer and Identification of Biological Response Biomarkers
Lead sponsor
Poitiers University Hospital
Phase
Not applicable
Overall status
Not yet recruiting
Start date
June 1, 2026
Completion date
February 1, 2027
Enrollment
42 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, breast lesions, endocrine disruptors, metabolomics